New program aims to curb antibiotic overuse in nursing homes
NCT ID NCT07246382
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a customizable program called ORANEAT to help French nursing homes use antibiotics more responsibly. The program includes a check of current practices, a toolkit of actions, and support from local experts. Researchers will compare antibiotic use in 66 nursing homes that use the program versus those that don't, to see if it works and can be sustained.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
customizable antibiotic stewardship program (ORANEAT)
What this could lead to
If successful, this could provide an effective, adaptable program to reduce antibiotic overuse in nursing homes, helping fight antibiotic resistance.
What could go wrong
This is a small, early-stage study in specific French regions, so results may not apply elsewhere. The program's complexity may also make it hard to implement consistently.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIBACTERIAL AGENTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••